Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Efrat Lelkes, MD, Angira Patel, MD, MPH, Anna Joong, MD, and Jeffrey G. Gossett, MD
Current policy requires separate informed consent for some Public Health Service increased-risk donors, and this can make shared decision making harder.
AMA J Ethics. 2020;22(5):E401-407. doi:
10.1001/amajethics.2020.401.
Mary Perkinson, DMA, Vaishali Phatak, PhD, and Meghan K. Ramirez
There is evidence of the benefits of music for health and wellness, but current US clinical practice does not yet commonly incorporate arts-based interventions.
AMA J Ethics. 2022;24(7):E611-616. doi:
10.1001/amajethics.2022.611.